60 Seconds with...Larry Minnix

Share this article:
Larry Minnix, LeadingAge president and CEO
Larry Minnix, LeadingAge president and CEO
Q: What is the next big issue, post-CLASS Act?

A: This is an era of transformation. What we're saying to our members is over the next decade it's probably going to be the greatest change that our members have encountered in generations.

Q: What will be needed?

A: The triple-aim we've got to really figure out is how to focus on resident-centered care. We're going to have to figure out how to create much better community approaches to services. And the result of that, we already know through smaller pilot efforts, is that you can increase people's quality of life at less cost. That's really the objective of the next decade.

Q: LeadingAge just celebrated its 50th anniversary. What do you see as opportunities and challenges for the association's next 50 years?


A: No. 1 is the transformation. No. 2, we've got to look at ways to finance everything we're doing differently. We're really focusing on human resources, as we call it, the “talent side” … how to attract and retain the next generations. And interestingly enough, how to attract and retain current generations of people who might normally think of themselves as retired but who have an important role to play.
Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.